Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Protein Priming Followed by a Replication-Competent VSV-GP Vector Boost Induces Sustained Immune Control in Therapeutic Hepatitis B Vaccination.

Vaccines·2026
Same author

Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir.

Npj viruses·2026
Same author

The cryo-EM structure of Photosystem I from Chromera velia with a bound superoxide dismutase heterodimer.

Nature communications·2025
Same author

Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits.

NPJ vaccines·2025
Same author

Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype.

Journal for immunotherapy of cancer·2025
Same author

Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patterns.

Vaccine·2025

相关实验视频

Updated: Jun 26, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

58.9K

使用膀性口炎病毒作为指导蛋白酶进化的平台.

Francesco Costacurta1,2, Stefanie Rauch1,2, Dorothee von Laer1

  • 1Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.

Current protocols
|December 23, 2024
PubMed
概括

这项研究提出了一种安全的方法,可以在不使用危险病毒的情况下识别抗病毒耐药性突变. 通过使用代理病毒,研究人员可以有效地研究病毒进化和耐药性.

关键词:
在Mpro Mpro中使用.在SARS-CoV-2中.冠状病毒 冠状病毒进化 进化 演化 演化 演化 演化蛋白酶抑制剂是一种蛋白酶抑制剂.电阻的电阻是指电阻的电阻膀性口腔炎病毒的病毒

更多相关视频

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
10:40

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

25.9K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.3K

相关实验视频

Last Updated: Jun 26, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

58.9K
Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
10:40

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

25.9K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.3K

科学领域:

  • 病毒学 病毒学
  • 分子生物学分子生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 抗病毒药物至关重要,但面临着快速演变的病毒的挑战.
  • 研究病毒耐药性对于有效的治疗至关重要,但对潜在的流行病病毒提出了安全问题.
  • 对高度致病性病毒的功能获取研究需要严格的安全协议.

研究的目的:

  • 开发一种选择抗病毒耐药性突变的安全协议.
  • 为研究病毒进化和耐药性的研究提供一种方法,而无需使用传染剂.
  • 建立一个可靠的测序管道,用于识别抗性突变.

主要方法:

  • 使用膀性口炎病毒 (VSV) 作为替代RNA病毒平台.
  • 工程VSV将其他病毒的转基因纳入,从而产生功能依赖.
  • 应用了针对转基因的抗病毒选择压力,以隔离耐药性突变.
  • 开发了一种用于突变分析的高通量测序管道.

主要成果:

  • 通过使用代用VSV系统成功展示了一种选择抗病毒耐药性突变的方法.
  • 创建了一个针对病毒耐药性的指导演变的综合性协议.
  • 建立并验证了一条测序管道,以有效识别突变.

结论:

  • 替代VSV系统为研究抗病毒耐药机制提供了安全有效的替代方案.
  • 这种方法有助于在抗病毒药物开发和治疗策略方面做出明智的决策.
  • 协议和测序管道可以加速对病毒进化和耐药性的研究.